FIASCHI, LIA
 Distribuzione geografica
Continente #
EU - Europa 233
NA - Nord America 108
AS - Asia 36
AF - Africa 2
SA - Sud America 2
Totale 381
Nazione #
IT - Italia 107
US - Stati Uniti d'America 106
IE - Irlanda 49
RU - Federazione Russa 31
DE - Germania 20
SG - Singapore 20
FI - Finlandia 11
CN - Cina 9
SE - Svezia 5
CA - Canada 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
FR - Francia 1
GB - Regno Unito 1
GE - Georgia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
VN - Vietnam 1
Totale 381
Città #
Siena 63
Dublin 49
Santa Clara 41
Singapore 16
Munich 10
New York 10
Ashburn 9
Florence 8
Helsinki 8
Chandler 7
Shanghai 5
Leipzig 4
Brescia 3
Lappeenranta 3
Los Angeles 3
Abidjan 2
Bergamo 2
Boardman 2
Brno 2
Columbus 2
Dallas 2
Magdeburg 2
Milan 2
Naples 2
Novate Milanese 2
Perugia 2
Rome 2
Toronto 2
Turin 2
Afragola 1
Agrigento 1
Almaty 1
Bad Bellingen 1
Baku 1
Brussels 1
Chicago 1
Chisinau 1
Colombo 1
Dezhou 1
Frattamaggiore 1
Gdynia 1
Guangzhou 1
Hong Kong 1
Kürten 1
Lastra a Signa 1
Lima 1
London 1
Luoyang 1
Modena 1
Montelupo Fiorentino 1
Málaga 1
Pasadena 1
Pisa 1
Santa Croce sull'Arno 1
Santiago Metropolitan 1
Sofia 1
Tbilisi 1
Varese 1
Washington 1
Totale 297
Nome #
Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm 66
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 59
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 52
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy 47
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 45
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination 37
Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy 33
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants 31
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 29
A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations 15
Totale 414
Categoria #
all - tutte 2.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202347 0 0 0 1 12 17 3 6 1 1 5 1
2023/2024149 3 6 17 17 0 22 32 19 4 8 1 20
2024/2025218 15 9 64 56 49 25 0 0 0 0 0 0
Totale 414